SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?


To: Montana Wildhack who wrote (8176)12/6/2001 11:58:33 AM
From: Joe Krupa  Respond to of 14101
 
TSE Market By Price
Bid
Orders Volume Price
3 6,900 4.35
1 1,500 4.32
1 1,000 4.30
1 12,000 4.28
1 5,000 4.26
Ask
Price Volume Orders
4.39 2,000 1
4.40 1,500 1
4.45 5,000 3
4.50 12,000 3
4.55 1,000 1



To: Montana Wildhack who wrote (8176)12/7/2001 2:53:42 PM
From: Cal Gary  Read Replies (2) | Respond to of 14101
 
Wolf,

I haven't kept up with my DMX cash burn spreadsheet.

What's the latest you have on it, especially with $9.2mm raised so far from Acqua.

Thanks in advance. Your numbers might give me confidence to think we are over hump of the financing mountain. An expensive expedition. If so, we should begin climbing back to $7.00 level where the financing started.



To: Montana Wildhack who wrote (8176)12/7/2001 3:19:11 PM
From: Joe Krupa  Read Replies (2) | Respond to of 14101
 
Wolf,

Very interesting discussion taking place on SH right now regarding the FDA plant inspection. It all starts with the following post by Barcelo:

stockhouse.com.

The FDA Inspected the Plant this week

The FDA inspected Dimethaid's plant in Varennes this week. I spoke directly to a very nice lady at the FDA and she confirmed the inspection was taking place.
She also said this is one of the final steps, and that approval of Pennsaid hinges on the results of the inspection.

I now expect approval in March. I think the trade secret details pertaining to Pennsaid is being discussed today at the Arthritis Advisory Committe meeting (just my opinion) and that it will publically be on the Arthritis Advisory Committee agenda in February if the plant passes the inspection. Expect approval 30 days later.